Nivolumab vs Strontium Ranelate

## Nivolumab vs Strontium Ranelate: Overview

This comparison examines the pharmacological differences between **Nivolumab** and **Strontium Ranelate**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Nivolumab — 27 days; Strontium Ranelate — N/A.

## Chemical Properties

**Type**: Nivolumab — Antibody; Strontium Ranelate — Small molecule.